Wellington Management Group LLP 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 10:11 am Sale |
2023-12-29 | 13G | Blueprint Medicines Corporation BPMC |
Wellington Management Group LLP | 4,276,333 7.030% |
-727,095 (-14.53%) |
Filing |
| 2023-02-06 2:49 pm Purchase |
2022-12-30 | 13G | Blueprint Medicines Corporation BPMC |
Wellington Management Group LLP | 5,003,428 8.360% |
1,526,103 (+43.89%) |
Filing |
| 2022-02-04 09:15 am Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
Wellington Management Group LLP | 3,477,325 5.910% |
2,440,695 (+235.45%) |
Filing |
| 2021-02-03 2:14 pm Sale |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
Wellington Management Group LLP | 1,036,630 1.860% |
-1,499,997 (-59.13%) |
Filing |